HSP90AA1 and sarcoma: Moreover, in combination, the CDK inhibitor (SCH727965) and the Hsp90 inhibitor (NVP-AUY922) were found to induce apoptosis and cell cycle disruption in sarcoma cells, while it spared the normal osteoblasts [27].